Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mustafa K Shehata, Assem A Ismail & Maher A Kamel. (2023) Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model. International Journal of Nanomedicine 18, pages 4193-4227.
Read now
Read now
Mustafa K Shehata, Assem A Ismail & Maher A Kamel. (2023) Nose to Brain Delivery of Astaxanthin–Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer’s Disease: Preparation, in vitro and in vivo Evaluation. International Journal of Nanomedicine 18, pages 1631-1658.
Read now
Read now
S.L Neha, Ashwini Kumar Mishra, Laxmi Rani, Suraj Pal Verma & Pravat Kumar Sahoo. (2022) Characterization and HPLC Method Validation for Determination of Dopamine Hydrochloride in Prepared Nano Particles and Pharmacokinetic Application. Analytical Chemistry Letters 12:4, pages 528-541.
Read now
Read now
Sara Cunha, Ben Forbes, José Manuel Sousa Lobo & Ana Catarina Silva. (2021) Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels. International Journal of Nanomedicine 16, pages 4373-4390.
Read now
Read now
Shourya Tripathi, Ujala Gupta, Rewati Raman Ujjwal & Awesh K. Yadav. (2021) Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route. Journal of Microencapsulation 38:7-8, pages 572-593.
Read now
Read now
Rosamaria Lombardo, Teresa Musumeci, Claudia Carbone & Rosario Pignatello. (2021) Nanotechnologies for intranasal drug delivery: an update of literature. Pharmaceutical Development and Technology 26:8, pages 824-845.
Read now
Read now
Shuqi Li, Jie Zhang, Yuqi Fang, Jun Yi, Zhufen Lu, Yanzhong Chen & Bohong Guo. (2020) Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique. Drug Design, Development and Therapy 14, pages 243-256.
Read now
Read now
Articles from other publishers (44)
Sweta Priyadarshini Pradhan, Pratap Kumar Sahu & Anindita Behera. (2023) New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer’s disease. Molecular and Cellular Biochemistry 478:12, pages 2739-2762.
Crossref
Crossref
Swapnali Vasant Birajdar, Farhan Mazahir & Awesh K. Yadav. (2023)
Transferrin Functionalized Poloxamer-Chitosan Nanoparticles of Metformin: Physicochemical Characterization,
In-vitro,
and
Ex-vivo
Studies
. Drug Development and Industrial Pharmacy, pages 1-18.
Crossref
Crossref
Shailvi Shah, Amit A. Patel, Bhupendra G. Prajapati, Amit Alexander, Vidhi Pandya, Nidhi Trivedi, Punit Pandey, Samir G. Patel & Ravish J. Patel. (2023) Multifaceted nanolipidic carriers: a modish stratagem accentuating nose-to-brain drug delivery. Journal of Nanoparticle Research 25:7.
Crossref
Crossref
Nicolás Navarro Martínez, Jorge Toledo Hernández & Javier O. Morales. (2023) Nanoparticles for the potential treatment of Alzheimer’s disease: A physiopathological approach. Nanotechnology Reviews 12:1.
Crossref
Crossref
Paramita Saha, Himanshu Kathuria & Murali Monohar Pandey. (2023) Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease. Journal of Controlled Release 358, pages 293-318.
Crossref
Crossref
Mina Todorova, Miglena Milusheva, Lidia Kaynarova, Deyana Georgieva, Vassil Delchev, Stanislava Simeonova, Bissera Pilicheva & Stoyanka Nikolova. (2023) Drug-Loaded Silver Nanoparticles—A Tool for Delivery of a Mebeverine Precursor in Inflammatory Bowel Diseases Treatment. Biomedicines 11:6, pages 1593.
Crossref
Crossref
Raquel Taléns-Visconti, Jesus Vicente de Julián-Ortiz, Ofelia Vila-Busó, Octavio Diez-Sales & Amparo Nácher. (2023) Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications. Pharmaceutics 15:5, pages 1399.
Crossref
Crossref
Varunesh Sanjay Tambe & Sarika Wairkar. (2023) Lipid-based Nanocarriers via Nose-to-Brain Pathway for Alzheimer's and
Parkinson's Disease. Current Nanoscience 19:3, pages 322-337.
Crossref
Crossref
Joana Torres, José Miguel Pereira, Rita Marques-Oliveira, Inês Costa, Eva Gil-Martins, Renata Silva, Fernando Remião, Andreia Filipa Peixoto, José Manuel Sousa Lobo & Ana Catarina Silva. (2023) An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies. Pharmaceutics 15:4, pages 1035.
Crossref
Crossref
B. Siva Lokesh, Prakash Haloi & V. Badireenath Konkimalla. (2023) Fabrication and optimization of BSA-PEG-loaded phenethyl isothiocyanate (PEITC) nanoparticles using Box-Behnken design for potential application in subcutaneous infection condition. Journal of Drug Delivery Science and Technology 80, pages 104101.
Crossref
Crossref
Maria Kannavou, Kanelina Karali, Theodora Katsila, Eleni Siapi, Antonia Marazioti, Pavlos Klepetsanis, Theodora Calogeropoulou, Ioannis Charalampopoulos & Sophia G. Antimisiaris. (2023) Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery. Pharmaceutics 15:2, pages 419.
Crossref
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors
255
297
.
Poonam Parashar & Jovita Kanoujia. 2023. Advanced Nanoformulations. Advanced Nanoformulations
311
340
.
María L. Formica, Daniel A. Real, Matías L. Picchio, Elise Catlin, Ryan F. Donnelly & Alejandro J. Paredes. (2022) On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today 29, pages 101631.
Crossref
Crossref
Subashini Raman, Arshad Ali Khan & Syed Mahmood. (2022) Nose to brain delivery of selegiline loaded PLGA/lipid nanoparticles: Synthesis, characterisation and brain pharmacokinetics evaluation. Journal of Drug Delivery Science and Technology 77, pages 103923.
Crossref
Crossref
Amarjitsing Rajput, Prashant Pingale & Vividha Dhapte-Pawar. (2022) Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects. Frontiers in Pharmacology 13.
Crossref
Crossref
Philippe Delbreil, Jean-Michel Rabanel, Xavier Banquy & Davide Brambilla. (2022) Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings. Advanced Drug Delivery Reviews 187, pages 114397.
Crossref
Crossref
Mara Alaide Guzmán-Ruiz, Adriana Jiménez, Alfredo Cárdenas-Rivera, Natalí N. Guerrero-Vargas, Diana Organista-Juárez & Rosalinda Guevara-Guzmán. (2021) Regulation of Metabolic Health by an “Olfactory-Hypothalamic Axis” and Its Possible Implications for the Development of Therapeutic Approaches for Obesity and T2D. Cellular and Molecular Neurobiology 42:6, pages 1727-1743.
Crossref
Crossref
Radka Boyuklieva & Bissera Pilicheva. (2022) Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines 10:7, pages 1706.
Crossref
Crossref
Line Séguy, Anne-Claire Groo & Aurélie Malzert-Fréon. (2022) How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment?. Drug Discovery Today 27:6, pages 1575-1589.
Crossref
Crossref
Bo Zhang, Yachai Gao, Xiaolei Zhang, Jicheng Jiang, Jian Ren, Shaoteng Wang, Haodong Hu, Yiping Zhao, Li Chen, Kongyin Zhao & Fengying Dai. (2022) Ultra-stable dextran conjugated prodrug micelles for oxidative stress and glycometabolic abnormality combination treatment of Alzheimer's disease. International Journal of Biological Macromolecules 203, pages 430-444.
Crossref
Crossref
Thi-Thao-Linh Nguyen & Han-Joo Maeng. (2022) Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery. Pharmaceutics 14:3, pages 572.
Crossref
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Nguyen-Minh-An Tran & Giau Van Vo. (2021) Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders. Neurochemical Research 47:3, pages 552-573.
Crossref
Crossref
Victoria Wolf, Yasir Abdul & Adviye Ergul. (2022) Novel Targets and Interventions for Cognitive Complications of Diabetes. Frontiers in Physiology 12.
Crossref
Crossref
Kyriaki Savva, Margarita Zachariou, Marilena M. Bourdakou, Nikolas Dietis & George M. Spyrou. (2022) Network-based stage-specific drug repurposing for Alzheimer’s disease. Computational and Structural Biotechnology Journal 20, pages 1427-1438.
Crossref
Crossref
David Lee & Tamara Minko. (2021) Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 13:12, pages 2049.
Crossref
Crossref
Marcelle Silva-Abreu, Esther Miralles, Christina S. Kamma-Lorger, Marta Espina, María Luisa García & Ana Cristina Calpena. (2021) Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis. Pharmaceutics 13:11, pages 1751.
Crossref
Crossref
C.P. Costa, S. Cunha, J.N. Moreira, R. Silva, E. Gil-Martins, V. Silva, L. Azevedo, A.F. Peixoto, J.M. Sousa Lobo & A.C. Silva. (2021) Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells. International Journal of Pharmaceutics 607, pages 120933.
Crossref
Crossref
Cláudia Pina Costa, Sandra Barreiro, João Nuno Moreira, Renata Silva, Hugo Almeida, José Manuel Sousa Lobo & Ana Catarina Silva. (2021) In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals 14:8, pages 711.
Crossref
Crossref
Esther Miralles-Cardiel, Marcelle Silva-Abreu, Ana Cristina Calpena & Isidre Casals. (2021) Development and Validation of an HPLC–MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues. Pharmaceutics 13:5, pages 650.
Crossref
Crossref
Angela Rampa, Silvia Gobbi, Federica Belluti & Alessandra Bisi. (2021) Tackling Alzheimer’s Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles. Current Medicinal Chemistry 28:12, pages 2305-2327.
Crossref
Crossref
Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo & Ana Catarina Silva. (2021) Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharmaceutica Sinica B 11:4, pages 925-940.
Crossref
Crossref
Ganesh B. Shevalkar, Mahendra K. Prajapati, Rohan V. Pai & Kamlesh D. Mali. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
249
266
.
Namdev Dhas, Dattatray Yadav, Ashutosh Singh, Atul Garkal, Ritu Kudarha, Priyanka Bangar, Jignasa Savjani, Chandrakantsing V. Pardeshi, Neha Garg & Tejal Mehta. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
15
37
.
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Dustin Chernick, Rui Zhong & Ling Li. (2020) The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease. Biomolecules 10:9, pages 1276.
Crossref
Crossref
Anupriya Anand, Bharadhwaj Ramesh Iyer, Chandrasekar Ponnusamy, Rajesh Pandiyan & Abimanyu Sugumaran. (2020) Design and Development of Lomustine Loaded Chitosan Nanoparticles for Efficient Brain Targeting. Cardiovascular & Hematological Agents in Medicinal Chemistry 18:1, pages 45-54.
Crossref
Crossref
Sara Cunha, Cláudia Pina Costa, Joana A. Loureiro, Jorge Alves, Andreia F. Peixoto, Ben Forbes, José Manuel Sousa Lobo & Ana Catarina Silva. (2020) Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters. Pharmaceutics 12:7, pages 599.
Crossref
Crossref
Anmol Dogra, R.S. Narang & Jasjeet K. Narang. (2020) Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design 26:19, pages 2257-2279.
Crossref
Crossref
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sunil Kumar Dubey, Anu Puri, Ravish J. Patel, Ajazuddin, V. Ravichandiran, Upadhyayula Suryanarayana Murty & Amit Alexander. (2020) Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. Journal of Controlled Release 321, pages 372-415.
Crossref
Crossref
Nivethaa E A K, Baskar S, Catherine Ann Martin, Ramana Ramya J, Stephen A, Narayanan V, Lakshmi B S, Olga V. Frank-Kamenetskaya, Subathra Radhakrishnan & Narayana Kalkura S. (2020) A competent bidrug loaded water soluble chitosan derivative for the effective inhibition of breast cancer. Scientific Reports 10:1.
Crossref
Crossref
Mario Muñoz-Jiménez, Alí Zaarkti, Juan Antonio García-Arnés & Natalia García-Casares. (2020) Antidiabetic Drugs in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review. Dementia and Geriatric Cognitive Disorders 49:5, pages 423-434.
Crossref
Crossref
Cristina Carvalho & Paula I. Moreira. 2020. Obesity and Diabetes. Obesity and Diabetes
399
414
.
Sushama Talegaonkar, Namrata Gautam, Venu Varshney, Sandeep Kumar Sharma & Arundhati Bhattacharyya. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
307
341
.